Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 February 2022 | Story Anthony Mthembu | Photo Sonia Small
UFS students

The University of the Free State realises that the registration period can be stressful and frustrating to students for various reasons. 

In an effort to ensure that as many students as possible can successfully register for the 2022 academic year, the University of the Free State (UFS) has introduced a number of financial concessions. These financial concessions are specifically intended to fast-track the registration process of students who are currently awaiting confirmation of funding from the National Student Financial Aid Scheme (NSFAS).

Students with challenges regarding the application of the N+ rule

Students who have previously registered for foundation programmes and those who have continued with mainstream programmes will be allowed to register without the prerequisite of a first payment. This is on condition that they apply with the N+ rule (an added year of funding) and that their respective foundation programmes are included in the Department of Higher Education and Training (DHET)-funded list. Only students who do not have outstanding debt will qualify for this concession. 

2022 NSFAS-funded students

In addition, students whose funding has been confirmed by NSFAS for the 2022 academic year, will be permitted to register without a first payment.

Students without NSFAS 2022 funding confirmation with outstanding debt

Students awaiting NSFAS funding confirmation for 2022 will be allowed to register provisionally if their debt does not exceed R25 000.
Approval has been obtained to increase the maximum debt carried forward from 2021 from R20 000 to R25 000 to enable students to register provisionally.

Provisional registration for continuing NSFAS students 

Furthermore, continuing NSFAS students who are currently awaiting funding confirmation for the 2022 academic year, will be permitted to register provisionally. These are students
• who have been funded by NSFAS in 2021; 
• whose funding reflects on the NSFAS Bursary Agreement Report for the year 2021; and
• who have passed 50% of registered modules in 2021 or are in their final year in 2022. 
• The offer for continuing students to register provisionally also extend to those who are in the N+1 period. 

The official registration of these students will be subject to funding approval from NSFAS for the 2022 academic year. To ensure that all students are in classes on 21 February 2022, the abovementioned group of students have until 31 March 2022 to confirm their funding. 

Conditional registration for first-time entering students

With registration an overwhelming experience for first-time entering students, the UFS is also looking at concessions for these students who will start their studies at the university this year. 

The university has given first-time entering students who have applied for NSFAS funding and are awaiting confirmation, until 28 February 2022 to finalise their registration. 

Permission to finalise registration a week after the UFS registration cut-off time is granted to all South African first-time entering undergraduate students who are admitted and term-activated for 2022 NSFAS-funded academic programmes, and whose funding has not yet been confirmed. 

The amount payable for conditional registration for first-time entering students (residential and non-residential) is R500.

The UFS is hopeful that these financial concessions will assist in calming anxiety around the ongoing registration process.


News Archive

#Women'sMonth: Save the children
2017-08-10

Description: Trudi O'Neill Tags: : rotaviruses, young children, Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology, vaccine 

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines 
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach 

When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.” 

A future without rotavirus vaccination?

Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept